Various forms of contrast media have been used to improve medical imaging.
• Their value has long been recognized, as attested to by their common daily use
in imaging departments worldwide.
• Like all other pharmaceuticals, however, these agents are not completely devoid
of risk.
• Adverse side effects from the administration of contrast media vary from minor
physiological disturbances to rare severe life-threatening situations.
• Preparation for prompt treatment of contrast media reactions must include
preparation for the entire spectrum of potential adverse events and include
prearranged response planning with availability of appropriately trained
personnel, equipment, and medications.
• Thorough familiarity with the presentation and emergency treatment of
contrast media reactions must be part of the environment in which all
intravascular contrast media are administered.
VERY BASICS OF CONTRAST MEDIA IN RADIOLOGY.
CLASSIFICATION OF CONTRAST MEDIA.
APPLICATION OF CONTRAST MEDIA.
XRAY, CT, ULTRASOUND AND MRI CONTRAST AGENTS.
Adverse reactions and management of contrast reactions Ashim Budhathoki
Contrast agents have evolved significantly over the past century, from barium and iodine-based agents that were used initially by medical practitioners and radiologists, to the more advanced agents like radiopharmaceuticals and gold nanoparticles that are currently in use. Current radiological imaging uses electromagnetic radiation (X ray, radiowaave), or ultrasound. Contrast agents may be used with all of these imaging techniques to enhance the differences seen between the body tissues on the image.
iodinated and gadolinium Contrast media are widely used in imaging. The radiologist and the physician should be familiar with the common side effects and the serious life threatening adverse reactions,
VERY BASICS OF CONTRAST MEDIA IN RADIOLOGY.
CLASSIFICATION OF CONTRAST MEDIA.
APPLICATION OF CONTRAST MEDIA.
XRAY, CT, ULTRASOUND AND MRI CONTRAST AGENTS.
Adverse reactions and management of contrast reactions Ashim Budhathoki
Contrast agents have evolved significantly over the past century, from barium and iodine-based agents that were used initially by medical practitioners and radiologists, to the more advanced agents like radiopharmaceuticals and gold nanoparticles that are currently in use. Current radiological imaging uses electromagnetic radiation (X ray, radiowaave), or ultrasound. Contrast agents may be used with all of these imaging techniques to enhance the differences seen between the body tissues on the image.
iodinated and gadolinium Contrast media are widely used in imaging. The radiologist and the physician should be familiar with the common side effects and the serious life threatening adverse reactions,
"Navigating Anti-Epileptic Drug Choices with Dr. Ganesh"
🌟 Greetings, friends! Welcome back to the channel. I'm Dr. Ganesh, and today we're delving into a crucial topic: the selection of Anti-Epileptic Drugs (AEDs). If you or someone you know is dealing with epilepsy, understanding the choices and considerations involved in AEDs is vital for effective management.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
2. INTRODACTION
Various forms of contrast media have been used to improve medical imaging.
• Their value has long been recognized, as attested to by their common daily use
in imaging departments worldwide.
• Like all other pharmaceuticals, however, these agents are not completely devoid
of risk.
• Adverse side effects from the administration of contrast media vary from minor
physiological disturbances to rare severe life-threatening situations.
• Preparation for prompt treatment of contrast media reactions must include
preparation for the entire spectrum of potential adverse events and include
prearranged response planning with availability of appropriately trained
personnel, equipment, and medications.
• Thorough familiarity with the presentation and emergency treatment of
contrast media reactions must be part of the environment in which all
intravascular contrast media are administered.
3. As would be appropriate with any diagnostic procedure, preliminary
considerations for the
referring physician and the radiologist include:
1. Assessment of patient risk versus potential benefit of the contrast assisted
examination.
2. Imaging alternatives that would provide the same or better diagnostic
information.
3. Assurance of a valid clinical indication for each contrast medium
administration.
Because of the documented low incidence of adverse events, intravenous
injection of
contrast media may be exempted from the need for informed consent, but
this decision
should be based on state law, institutional policy, and departmental policy.
4. The approach to patients about to undergo a contrast-enhanced examination has three
general goals:
1) to assure that the administration of contrast is appropriate for the patient and the
indication;
2) to minimize the likelihood of a contrast reaction; and
3) to be fully prepared to treat a reaction should one occur
Achieving these aims depends on :
• obtaining an appropriate and adequate history for each patient,
• preparing the patient appropriately for the examination,
• having equipment available to treat reactions, and
• ensuring that expertise sufficient to treat even the most severe reactions is readily at
hand.
Although mild reactions to contrast media are relatively common, they are almost invariably
self-limited and of no consequence.
Severe, life threatening reactions, although rare, can occur in the absence of any specific
risk factors with any type of media.
5. RISK FACTORS FOR ADVERSE
REACTIONS
• Previous contrast reaction
• Type of contrast agent
• Allergy
• Asthma
• Renal insufficiency
• Cardiovascular disease
• Diabetes
• Anxiety
• Multiple myeloma
• Beta-blockers
• Sickle cell disease
• Age
• Concomitant use of intra-arterial medications like papavarine
• Pheochromocytoma
• Hyperthyroidism
• Myasthenia Gravis
6.
7. IDIOSYNCRATIC REACTIONS
Definition :
unpredictable reactions which occur within 1 hour
of contrast medium administration and which are
unrelated to the dose of the contrast medium
above a certain level.
• Serious and most dreaded
• Occur without warning
• Cannot be reliably predicted
8.
9.
10.
11. INITIAL APPROACH – ABC of Critical care
A – Airway
B – Breathing
C – Circulation
Call for help immediately while
resuscitating – do not hesitate
12. Management of moderate reactions
1. URTICARIA
Urticaria, also known as hives, is an outbreak of swollen, pale red
bumps or plaques (wheals) on the skin that appear suddenly -- either
as a result of the body's reaction to certain allergens, or for unknown
reasons.
• Discontinue the injection if not
completed
• No Rx in most cases
• H1-receptor blocker:
Diphenhydramine IV/IM/PO 25-50
mg
• Severe or widely disseminated
urticaria –Adrenaline (1:1000) 0.1-
0.3 ml SC (if no contraindications)
13. Management of moderate reactions
2. Facial or laryngeal edema
Oxygen @6-10 L/min (by
mask)
• Adrenaline SC or IM 0.1-
0.3 ml of 1:1000
• If Hypotension is present
– Adrenaline 3 ml of
1:10000 IV preferably
under ECG monitoring
• If not responsive – can be
repeated upto 1 mg
• Always seek appropriate
assisstance in nonresponsive
cases
14. Management of moderate reactions
3. Bronchospasm
• Oxygen 6-10L/min (mask)
• ECG, Saturation, BP
• Beta-agonist inhalers
(bronchodilators : terbutaline,
albuterol, metaproterenol) 2-3 puffs:
repeat as necessary
• IV/IM/SC adrenaline if not
responding
• IM/SC : 0.1-0.3 ml (1:1000)
• If hypotension – IV slow 1-3 ml (
1:10000) under ECG monitoring
• Max dose upto 1 mg
• Assistance must be sought in case of
non-responders and if SPO2 <88%
15. Management of Severe Reactions
1. Hypotension with tachycardia
• Legs elevated or Trendelenberg position
• ECG, Saturation, BP
• Oxygen @6-10 L/min (mask)
• Rapid IV fluids [ Ringer Lactate/NS)
• If poorly responsive, IV Adrenaline
1:10000 1 ml up to max 1 mg dose
• Appropriate assistance must be sought
16. 2. Hypotension with Bradycardia (Vagal
reaction)
• Secure airway. Oxygen 6-10 L/min
• Monitor vitals
• Raise Legs >60 deg or Trendelenberg
position
• IV fluids : Ringer lactate/NS
• Atropine 0.6-1 mg IV slow , max dose
Upto 0.04mg/kg (2-3 mg) in adult
• Complete resolution of bradycardia and
hypotension before discharge
17. 3. Hypertension (severe)
Oxygen @ 6-10 L/min (mask)
Monitor ECG, Saturation, BP
Nitroglycerine 0.4 mg Tab, Sublingual ( may repeat x 3 times) or,
topical 2%
ointment, apply 1-inch strip
If not responsive, then Labetalol 20 mg IV stat, F/B 20-80 mg IV every
10 minutes
upto a maximum of 300 mg.
Shift to ICU or emergency medicine department
For Pheochromocytoma – Phentolamine 5 mg IV . (may use Labetolol if
Phentolamine is not available)
18. 4. Seizures
• Oxygen @ 6-10 ml/min (mask)
• Diazepam 5 mg IV ( or more as appropriate) or midazolam
0.5 – 1 mg IV
• Phenytoin 15-18 mg/kg @ 50 mg/min for longer effect –
after physician
consultation.
• Benzodiazepines may cause respiratory depression – close
monitoring of vitals is
necessary
• Appropriate assistance must be sought
19. 5. Pulmonary edema
• Oxygen @ 6-10 ml/min (mask)
• Elevate torso
• IV diuretic – furosemide 20-40 mg IV slow
• Consider morphine (1-3 mg IV).
• Shift to ICU or Emergency medicine
department
20. Non-Idiosyncratic reactions
Definition : These are dose related reactions and depend upon the physiochemical
properties of the contrast medium, i.e. chemical composiion,
Osmolality and concentration of the injected contrast and also on the volume,
speed and multiplicity of the injection.
Reactions unrelated to contrast media :
• Pyrogenic
• Vasovagal
• Excessive dehydration
• Hypertensive crisis in pheochromocytoma
• Hypoglycemia
Chemotoxic
• Cardiovascular
• Neurologic
• Renal
21. Hyperosmolar reactions :
Due to very high osmolarity of HOCMs –
erythrocyte damage, BBB damage, endothelial
damage, vaodalitation,
hypervolemia and cardiac depression.
22. CONTRAST EXTRAVASATION
• It refers to the escape of the contrast material from the vessel in which it is
introduced, into the surrounding tissue or body cavity
• 0.1-0.9% of contrast injections
• Risk factors :
Atherosclerosis, PVD, Diabetes, Raynaud’s disease, Venous
thrombosis, prior radiation, extensive surgery, severely ill and deblitated,
indwelling lines > 24 hrs, multiple injections in onto same vein.
• Clinical features :
Mild – edema, erythema, stinging, tenderness
Severe – Compartment syndrome, ulcers, necrosis
• Prevention is better than cure – ensure properly secured IV access, extravasation
detectors
• Treatment – depends on the volume of extravasation